Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.87 - $1.71 $15,834 - $31,122
18,200 Added 92.86%
37,800 $64,000
Q2 2023

Aug 11, 2023

BUY
$0.83 - $1.18 $16,268 - $23,128
19,600 New
19,600 $22,000
Q2 2022

Aug 15, 2022

BUY
$1.75 - $11.34 $88,375 - $572,670
50,500 Added 376.87%
63,900 $157,000
Q1 2022

May 16, 2022

SELL
$10.21 - $20.29 $30,630 - $60,870
-3,000 Reduced 18.29%
13,400 $137,000
Q4 2021

Feb 14, 2022

BUY
$16.76 - $22.99 $90,504 - $124,145
5,400 Added 49.09%
16,400 $323,000
Q3 2021

Nov 15, 2021

BUY
$13.15 - $22.56 $144,650 - $248,160
11,000 New
11,000 $203,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.26B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.